{
    "id": "dbpedia_4589_2",
    "rank": 30,
    "data": {
        "url": "https://snmmi.org/Web/Web/Research-Publications/Grants-Awards-and-Scholarships/2024-SNMMI-and-SNMMI-TS-Grants-and-Awards-Recipients.aspx",
        "read_more_link": "",
        "language": "en",
        "title": "2024 SNMMI and SNMMI-TS Grants and Awards Recipients",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://snmmi.org/images/web/logos/2023SNMMILogo.png",
            "https://snmmi.org/images/web/logos/2023SNMMILogo_300x95wh.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "/images/web/logos/snmmi-favicon.png",
        "meta_site_name": "",
        "canonical_link": "https://snmmi.org/Web/Web/Research-Publications/Grants-Awards-and-Scholarships/2024-SNMMI-and-SNMMI-TS-Grants-and-Awards-Recipients.aspx",
        "text": "2024 Grants and Awards Recipients (funded by SNMMI)\n\nMinoshima-Pappas Transformative Leadership Award - Richard Wahl, MD, FACR, FACNM, FSNMMI\n\nLalita and Mathew (Madhukar) Thakur Award - Olujide Oyeniran\n\n2024 Grants and Awards Recipients (funded by SNMMI-TS)\n\nSNMMI-TS Outstanding Technologist - Nadine Colpo, RTNM, PET\n\nKathy Thompson Hunt Outstanding Educator Award - Courtney Cross, MBA, RT(N)(CT), CNMT\n\n2024 Grants and Awards Recipients (funded by WINM)\n\nWomen in Nuclear Medicine Rising Star Award- Shana Elman, MD\n\nWomen in Nuclear Medicine She Paved the Way Lifetime Achievement Award - Twyla Bartel, DO, MBA, FACNM, FSNMMI\n\n2024 Grants and Awards Recipient (funded by the ARRT)\n\nSNMMI-TS Career Advancement Award - Fernando Anleu, Ejda Bajric, Nicole Beaulieu, Courtney Cross, Morgan Dunnivan, Keexia Osborne\n\n2024 Grants and Awards Recipients (funded by the Nihon Medi-Physics)\n\n2024-2026 Wagner-Torizuka Fellowship Program - Hidesato Fujito, MD; Koichiro Kimura, MD; Tomoaki Otani, MD, PhD\n\n2024 Grant Recipients (funded by the SNMMI Value Initiative)\n\nMedical and Science Student Research Grant - Aditya Misra, Anuja Konda, Bella Salerno, Fardeen Ahmed, Luke Polson, Narjes, Hajimollaheydar, Suya Li, Uttkarsh Chaurasia, Vishnu Murthy\n\n2024 Grants and Awards Recipients (funded by the PDEF)\n\nPDEF Mickey Williams Minority Scholarship - Mike No and Justin Flores\n\nPDEF Professional Development Scholarship - Christopher Owens, CNMT, PET\n\nPDEF Travel Awards - Noelle Miozza, Megan Bloomhuff, Madison O'Dell, Camryn Cohn, Brady Scholten, Kennedy Ebert, Ting Yen Lee, Michael Maddalena, Alan Stuckey, Amanda Roby, C. David Gilmore, Zane Archibald\n\n2024 Council and Center Awards\n\nSaul Hertz Award - Michael Hofman, MBBS\n\nPeter E. Valk, MD Memorial Lecuteship Award - Farrokh Dehdashti, MD, FSNMMI\n\nGCNMC Lifetime Achievement Award - Bennett Greenspan, MD, FACNM, FSNMMI\n\nGCNMC Lectureship Award - Tim Van den Wyngaert, MD, PhD\n\nCIC Barry Siegel Lectureship Award - Steven Rowe, MD, PhD\n\nTracey Lynn Faber Award - Elena Marie Zannoni, PhD\n\nEdward Hoffman Lecture Award - Jinyi Qi, PhD\n\nKuhl Lassen Award - Gitte M. Knudsen, Md, PdD\n\nBerson-Yalow Award - Emily Murrell, PhD\n\nHermann Blumgart Award - Venkatesh L. Murthy, MD, PhD\n\nCVC Outstanding Educator Award - Mouaz Al-Mallah, MD\n\nAC Tom Miller Memorial Lectureship Award -David Brandon, MD\n\nAC Distinguished Service Award - n/a 2024\n\nAC Lifetime Achievement Award - Lisa Dickinson\n\nPIC Conway-Treves Award - n/a 2024\n\nSally W. Schwarz Award - Stephen Dragotakes, BS, RPh, BCNP, FAPhA\n\nCMIIT Laboratory Professional Recognition Award for Contributions to Molecular Imaging - Armando Garcia, BSc\n\n2024 Grants and Awards Recipients (funded by the ERF)\n\nSam Gambhir, MD Trailblazer Award - Michael Evans, PhD\n\nArthur M. Weis, PhD, Award in Radiation Dosimetry and Safety - Zhonglin Lu\n\nMichael J. Welch Award - Suzanne E. Lapi, PhD\n\nMichael J. Welch Postdoctoral Grant - Yang Su\n\nMitzi & William Blahd, MD, Pilot Research Grant - Elena Marie Zannoni, PhD\n\nRobert E. Henkin, MD, Government Relations Fellowship - Joseph Steiner, PhD\n\nUrsula Mary-Kocemba Slosky, PhD, Professional Relations Fellowship -n/a 2024\n\nERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty - n/a 2024\n\nERF SNMMI Postdoctoral Molecular Imaging Scholar Program - n/a 2024\n\nBradley-Alavi Student Fellowships: Pratheek Reddy and Zekun Li\n\nPaul C. Aebersold, PhD Award - George Sgouros, PhD\n\nThe Sipra and Gopal Saha Scholarship - Zachary Olson and Andrew Voter\n\nAlavi-Mandell Awards Published in 2023 -\n\n225Ac-MACROPATATE: A Novel a-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors\n\nPaden King, Nicholas T. Gutsche, Natarajan Raju, Stanley Fayn, Kwamena E. Baidoo, Meghan M. Bell, Colleen S. Olkowski, Rolf E. Swenson, Frank I. Lin, Samira M. Sadowski, Stephen S. Adler, Nikki A. Thiele, Justin J. Wilson, Peter L. Choyke, and Freddy E. Escorcia\n\nMolecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland\n\nJ Nucl Med 2023; 64:549–554\n\nEvaluation of [68Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space\n\nAleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, Yan Li, Manuel Weber, Wolfgang P. Fendler, Julian Kirchner, Philipp Damman, Karsten Wrede, Lazaros Lazaridis, Martin Glas, Maja Guberina, Anja Eckstein, Tobias Blau, Ken Herrmann, Lale Umutlu, Michael Forsting, Cornelius Deuschl, and Benedikt Schaarschmidt\n\nInstitute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Düsseldorf, Germany\n\nJ Nucl Med 2023; 64:1185–1190\n\nMembrane and Nuclear Absorbed Doses from 177Lu and 161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study\n\nAlexandre Larouze, Mario Alcocer-Ávila, Clément Morgat, Christophe Champion, and Elif Hindié\n\nUniversité de Bordeaux–CNRS-CEA, Centre Lasers Intenses et Applications, UMR 5107, Talence, France\n\nJ Nucl Med 2023; 64:1619–1624\n\nHuman Epidermal Growth Factor Receptor 2–Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer\n\nAli Alhuseinalkhudhur, Henrik Lindman, Per Liss, Tora Sundin, Fredrik Y. Frejd, Johan Hartman, Victor Iyer, Joachim Feldwisch, Mark Lubberink, Caroline Rönnlund, Vladimir Tolmachev, Irina Velikyan, and Jens Sörensen\n\nDivision of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden\n\nJ Nucl Med 2023; 64:1364–1370\n\n177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers\n\nAmir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, and Isabel Rauscher\n\nDepartment of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:402–409\n\nThe Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy\n\nAmir Karimzadeh, Matthias Heck, Robert Tauber, Esteban Solaris, Stephan Nekolla, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, and Isabel Rauscher\n\nDepartment of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:1252–1258\n\nImproved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T\n\nAmir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, Charlotte-Sophie Hecker, Karina Knorr, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, and Isabel Rauscher\n\nDepartment of Nuclear Medicine, School of Medicine, Technical University of Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:1765–1771\n\n68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer\n\nAnouk C. de Jong, Marcel Segbers, Sui Wai Ling, Laura H. Graven, Niven Mehra, Paul Hamberg, Tessa Brabander, Ronald de Wit, and Astrid A.M. van der Veldt\n\nDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands\n\nJ Nucl Med 2023; 64:1556–1562\n\nThe Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework\n\nArthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernandez-Arias, Nesrine Rahmouni, Firoza Z. Lussier, Marie Vermeiren, Gleb Bezgin, Paolo Vitali, Kok Pin Ng, Eduardo R. Zimmer, Marie-Christine Guiot, Tharick A. Pascoal, Serge Gauthier, and Pedro Rosa-Neto\n\nDepartment of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada\n\nJ Nucl Med 2023; 64:1171–1178\n\nDiagnostic Accuracy of 99mTc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses\n\nAshwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa R. Schmidt, Robert S. Figenshau, Farrokh Dehdashti, and Richard L. Wahl\n\nMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri\n\nJ Nucl Med 2023; 64:90–95\n\nAdverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing 99mTc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience\n\nAshwin Singh Parihar, Lisa R. Schmidt, John Crandall, Farrokh Dehdashti, and Richard L. Wahl\n\nMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri\n\nJ Nucl Med 2023; 64:485–490\n\nMultimodality Imaging of Aortic Valve Calcification and Function in a Murine Model of Calcific Aortic Valve Disease and Bicuspid Aortic Valve\n\nAzmi A. Ahmad, Mean Ghim, Jakub Toczek, Afarin Neishabouri, Devi Ojha, Zhengxing Zhang, Kiran Gona, Muhammad Zawwad Raza, Jae-Joon Jung, Gunjan Kukreja, Jiasheng Zhang, Nicole Guerrera, Chi Liu, and Mehran M. Sadeghi\n\nYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, and Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut\n\nJ Nucl Med 2023; 64:1487–1494\n\nIntraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study\n\nBabs G. Sibinga Mulder, Marjory Koller, Evelien W. Duiker, Arantza Farina Sarasqueta, Jakobus Burggraaf, Vincent E. de Meijer, Alexander L. Vahrmeijer, Frederik J.H. Hoogwater, Bert A. Bonsing, Gooitzen M. van Dam, J. Sven D. Mieog, and Bobby K. Pranger\n\nDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands\n\nJ Nucl Med 2023; 64:82–89\n\nAmbient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via the pH Low-Insertion Peptide Conjugated to Indocyanine Green\n\nBenedict Edward Mc Larney, Mijin Kim, Sheryl Roberts, Magdalena Skubal, Hsiao-Ting Hsu, Anuja Ogirala, Edwin C. Pratt, Naga Vara Kishore Pillarsetty, Daniel A. Heller, Jason S. Lewis, and Jan Grimm\n\nMolecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York\n\nJ Nucl Med 2023; 64:1647–1653\n\nPSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study\n\nCaner Civan, Stefan Kasper, Christoph Berliner, Pedro Fragoso-Costa, Viktor Grünwald, Michael Pogorzelski, Benedikt Michael Schaarschmidt, Stephan Lang, David Kersting, Michael Nader, Katharina Lückerath, Ken Herrmann, Wolfgang P. Fendler, and Manuel Weber\n\nDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:372–378\n\nEvaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy\n\nCassis Varlow and Neil Vasdev\n\nAzrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada\n\nJ Nucl Med 2023; 64:460–465\n\nTandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer\n\nCatherine Meyer, Andreea Stuparu, Katharina Lueckerath, Jeremie Calais, Johannes Czernin, Roger Slavik, and Magnus Dahlbom\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California\n\nJ Nucl Med 2023; 64:1772–1778\n\nThe Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions\n\nCécile Tissot, Stijn Servaes, Firoza Z. Lussier, João Pedro Ferrari-Souza, Joseph Therriault, Pâmela C.L. Ferreira, Gleb Bezgin, Bruna Bellaver, Douglas Teixeira Leffa, Sulantha S. Mathotaarachchi, Mira Chamoun, Jenna Stevenson, Nesrine Rahmouni, Min Su Kang, Vanessa Pallen, Nina Margherita-Poltronetti, Yi-Ting Wang, Jaime Fernandez-Arias, Andrea L. Benedet, Eduardo R. Zimmer, Jean-Paul Soucy, Dana L. Tudorascu, Annie D. Cohen, Madeleine Sharp, Serge Gauthier, Gassan Massarweh, Brian Lopresti, William E. Klunk, Suzanne L. Baker, Victor L. Villemagne, Pedro Rosa-Neto, and Tharick A. Pascoal\n\nMcGill University, Montreal, Quebec, Canada\n\nJ Nucl Med 2023; 64:452–459\n\nEarly-Phase 18F-Florbetapir and 18F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting\n\nCecilia Boccalini, Débora Elisa Peretti, Federica Ribaldi, Max Scheffler, Sara Stampacchia, Szymon Tomczyk, Cristelle Rodriguez, Marie-Louise Montandon, Sven Haller, Panteleimon Giannakopoulos, Giovanni B. Frisoni, Daniela Perani, and Valentina Garibotto\n\nLaboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland\n\nJ Nucl Med 2023; 64:266–273\n\nSingle-Time-Point Imaging for Dosimetry After [177Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection\n\nChang Wang, Avery B. Peterson, Ka Kit Wong, Molly E. Roseland, Matthew J. Schipper, and Yuni K. Dewaraja\n\nDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan\n\nJ Nucl Med 2023; 64:1463–1470\n\n161Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of 161Tb into the Clinic\n\nChiara Favaretto, Pascal V. Grundler, Zeynep Talip, Stefan Landolt, Lebogang Sepini, Ulli Köster, Cristina Müller, Roger Schibli, Susanne Geistlich, and Nicholas P. van der Meulen\n\nCenter for Radiopharmaceutical Sciences, ETH–Paul Scherrer Institute, Villigen-PSI, Switzerland\n\nJ Nucl Med 2023; 64:1138–1144\n\n18F-FDG PET/CT in the Management of Osteosarcoma\n\nChiwoo Oh, Michael W. Bishop, Steve Y. Cho, Hyung-Jun Im, and Barry L. Shulkin\n\nDepartment of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea\n\nJ Nucl Med 2023; 64:842–851\n\nAn Analysis of the Distribution of PSMA PET/CT–Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients\n\nChristian Trapp, Dmytro Oliinyk, Paul Rogowski, Rieke von Bestenbostel, Ute Ganswindt, Minglun Li, Chukwuka Eze, Peter Bartenstein, Leonie Beyer, Harun Ilhan, Gabriel Sheikh, Lena Unterrainer, Christian Stief, Thilo Westhofen, Wolfgang G. Kunz, Marcus Unterrainer, Claus Belka, and Nina-Sophie Schmidt-Hegemann\n\nDepartment of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:918–923\n\nMolecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma\n\nChristina Laschinsky, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P. Fendler, and Manuel Weber\n\nDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:1865–1868\n\nGadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy\n\nClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, Ali Parach, Alejandro Bertolet, Marta Jarlier, Sophie Poty, Daniel Suarez Garcia, Wook-Geun Shin, Stanislas Du Manoir, Jan Schuemann, Olivier Tillement, François Lux, Julie Constanzo, and Jean-Pierre Pouget\n\nInstitut de Recherche en Cancérologie de Montpellier, Inserm U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France\n\nJ Nucl Med 2023; 64:1956–1964\n\nLesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy\n\nDavid Kersting, Walter Jentzen, Daniel Jeromin, Ilektra-Antonia Mavroeidi, Maurizio Conti, Florian Büther, Ken Herrmann, Christoph Rischpler, Rainer Hamacher, Wolfgang P. Fendler, Robert Seifert, and Pedro Fragoso Costa\n\nDepartment of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:329–336\n\n68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study\n\nDavid Kersting, Patrick Sandach, Miriam Sraieb, Marcel Wiesweg, Martin Metzenmacher, Kaid Darwiche, Filiz Oezkan, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Rainer Hamacher, Wolfgang P. Fendler, Johannes Wienker, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, and Hubertus Hautzel\n\nDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:1540–1549\n\nLongitudinal Tau PET Using 18F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters\n\nDenise Visser, Hayel Tuncel, Rik Ossenkoppele, Maqsood Yaqub, Emma E. Wolters, Tessa Timmers, Emma Weltings, Emma M. Coomans, Marijke E. den Hollander, Wiesje M. van der Flier, Bart N.M. van Berckel, and Sandeep S.V. Golla\n\nDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands\n\nJ Nucl Med 2023; 64:281–286\n\nEvaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden\n\nDenise A. Gococo-Benore, Justin Kuhlman, Ephraim E. Parent, Akash Sharma, Joseph Accurso, Ming Yang, Ayse Tuba Kendi, Geoff Johnson, Mohamad Bassam Sonbol, Timothy Hobday, Thorvardur R. Halfdanarson, and Jason Starr\n\nDepartment of Internal Medicine, Mayo Clinic, Jacksonville, Florida\n\nJ Nucl Med 2023; 64:880–884\n\n18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study\n\nElin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, Annouschka Laenen, Paul M. Clement, Karen Geboes, Eric Van Cutsem, Sigrid Stroobants, Chris Verslype, Guy Bormans, and Christophe M. Deroose\n\nNuclear Medicine, University Hospitals Leuven, and Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium\n\nJ Nucl Med 2023; 64:632–638\n\nLack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non–Small Cell Lung Cancer: Impact on Patient Outcomes\n\nEmily Sterbis, Rifei Liang, Premal Trivedi, Jennifer Kwak, Erica Cohen Major, Sana D. Karam, and Rustain L. Morgan\n\nDepartment of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado\n\nJ Nucl Med 2023; 64:75–81\n\nA Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum\n\nEmma M. Coomans, Inge M.W. Verberk, Rik Ossenkoppele, Sander C.J. Verfaillie, Denise Visser, Mariam Gouda, Hayel Tuncel, Emma E. Wolters, Tessa Timmers, Albert D. Windhorst, Sandeep S.V. Golla, Philip Scheltens, Wiesje M. van, der Flier, Bart N.M. van Berckel, and Charlotte E. Teunissen\n\nDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands\n\nJ Nucl Med 2023; 64:437–443\n\nImmuno-PET Detects Antibody–Drug Potency on Coadministration with Statins\n\nEmma L. Brown, Shayla Shmuel, Komal Mandleywala, Sandeep Surendra Panikar, Na-Keysha Berry, Yi Rao, Abbey Zidel, Jason S. Lewis, and Patrícia M.R. Pereira\n\nDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri\n\nJ Nucl Med 2023; 64:1638–1646\n\nTumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy\n\nEmma Mellhammar, Magnus Dahlbom, Oskar Vilhelmsson-Timmermand, and Sven-Erik Strand\n\nOncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden\n\nJ Nucl Med 2023; 64:1632–1637\n\nPET Imaging of Neutrophil Elastase with 11C-GW457427 in Acute Respiratory Distress Syndrome in Pigs\n\nEmmi Puuvuori, Elena Chiodaroli, Sergio Estrada, Pierre Cheung, Norbert Lubenow, Jonathan Sigfridsson, Hampus Romelin, Sofie Ingvast, Mathias Elgland, Francesco Liggieri, Olle Korsgren, Gaetano Perchiazzi, Olof Eriksson, and Gunnar Antoni\n\nScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden\n\nJ Nucl Med 2023; 64:423–429\n\nEstimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy\n\nErik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm, and Per Albertsson\n\nRegion Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden\n\nJ Nucl Med 2023; 64:165–172\n\nProspective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms\n\nEsben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, and Andreas Kjaer\n\nDepartment of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark\n\nJ Nucl Med 2023; 64:252–259\n\nDetection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease\n\nFarzaneh Rezazadeh, Nicholas Ramos, Allen-Dexter Saliganan, Najeeb Al-Hallak, Kang Chen, Bashar Mohamad, Wendy N. Wiesend, and Nerissa T. Viola\n\nDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan\n\nJ Nucl Med 2023; 64:1806–1814\n\nImaging Agents for PET of Inflammatory Bowel Disease: A Review\n\nFarzaneh Rezazadeh, Aidan P. Kilcline, and Nerissa T. Viola\n\nDepartment of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan\n\nJ Nucl Med 2023; 64:1858–1864\n\nPrognostic Value of Tumor Volume Assessment on PSMA PET After 177Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0\n\nFelix Kind, Ann-Christin Eder, Cordula A. Jilg, Philipp E. Hartrampf, Philipp T. Meyer, Juri Ruf, and Kerstin Michalski\n\nDepartment of Nuclear Medicine, Medical Center, University of Freiburg, Freiburg, Germany\n\nJ Nucl Med 2023; 64:605–610\n\n[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration\n\nGanna Blazhenets, David N. Soleimani-Meigooni, Wesley Thomas, Nidhi Mundada, Matthias Brendel, Stephanie Vento, Lawren VandeVrede, Hilary W. Heuer, Peter Ljubenkov, Julio C. Rojas, Miranda K. Chen, Alinda N. Amuiri, Zachary Miller, Maria L. Gorno-Tempini, Bruce L. Miller, Howie J. Rosen, Irene Litvan, Murray Grossman, Brad Boeve, Alexander Pantelyat, Maria Carmela Tartaglia, David J. Irwin, Brad C. Dickerson, Suzanne L. Baker, Adam L. Boxer, Gil D. Rabinovici, and Renaud La Joie\n\nMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California\n\nJ Nucl Med 2023; 64:1980–1989\n\nEvaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis\n\nGrayson Wass, Kari Clifford, and Rathan M. Subramaniam\n\nDepartment of Medicine, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand\n\nJ Nucl Med 2023; 64:1218–1224\n\nA Single-Arm, Low-Dose, Prospective Study of 177Lu-EB-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer\n\nGuochang Wang, Jie Zang, Yuanyuan Jiang, Qingxing Liu, Huimin Sui, Rongxi Wang, Xinrong Fan, Jingjing Zhang, Zhaohui Zhu, and Xiaoyuan Chen\n\nDepartment of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China\n\nJ Nucl Med 2023; 64:611–617\n\n18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use\n\nHannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, and Christophe M. Deroose\n\nNuclear Medicine, University Hospitals Leuven, and Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University of Leuven, Leuven, Belgium\n\nJ Nucl Med 2023; 64:835–841\n\nA Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Evaluation of Prostate Cancer Response to High-Intensity Focused Ultrasound Therapy\n\nHeying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Guido A. Davidzon, Carina Mari Aparici, Christian Kunder, Geoffrey A. Sonn, and Andrei Iagaru\n\nDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California\n\nJ Nucl Med 2023; 64:592–597\n\nA Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer\n\nHeying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Alan Thong, Christian Kunder, Carina Mari Aparici, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn, and Andrei Iagaru\n\nDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California\n\nJ Nucl Med 2023; 64:744–750\n\nThe Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer\n\nHinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx, and Berlinda J. de Wit-van der Veen\n\nDepartment of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands\n\nJ Nucl Med 2023; 64:63–68\n\nEfficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma\n\nInes Maric, Manuel Weber, Andre Prochnow, Jochen Schmitz, Nicole Unger, Benedikt M. Schaarschmidt, Thorsten D. Poeppel, Christoph Rischpler, Andreas Bockisch, Ken Herrmann, Walter Jentzen, and Wolfgang P. Fendler\n\nDepartment of Nuclear Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:885–891\n\nDifferences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial\n\nIsmaheel O. Lawal, Ashesh B. Jani, Omotayo A. Adediran, Subir Goyal, Olayinka A. Abiodun-Ojo, Vishal R. Dhere, Charles V. Marcus, Shreyas S. Joshi, Viraj A. Master, Pretesh R. Patel, Mark Goodman, Joseph W. Shelton, Omer Kucuk, Bruce Hershatter, Bridget Fielder, Raghuveer K. Halkar, and David M. Schuster\n\nDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia\n\nJ Nucl Med 2023; 64:586–591\n\nAntigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma\n\nJaehoon Shin, Matthew F.L. Parker, Iowis Zhu, Aryn Alanizi, Carlos I. Rodriguez, Raymond Liu, Payal B. Watchmaker, Mausam Kalita, Joseph Blecha, Justin Luu, Brian Wright, Suzanne E. Lapi, Robert R. Flavell, Hideho Okada, Thea D. Tlsty, Kole T. Roybal, and David M. Wilson\n\nDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California\n\nJ Nucl Med 2023; 64:137–144\n\nThe Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node–Negative Prostate Cancer Patients\n\nJan J. Duin, Hilda A. de Barros, Maarten L. Donswijk, Eva E. Schaake, Tim M. van der Sluis, Esther M.K. Wit, Fijs W.B. van Leeuwen, Pim J. van Leeuwen, and Henk G. van der Poel\n\nDepartment of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands\n\nJ Nucl Med 2023; 64:1563–1566\n\nClinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning\n\nJanna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Häberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhäberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers, and Julian Kirchner\n\nDepartment of Diagnostic and Interventional Radiology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany\n\nJ Nucl Med 2023; 64:304–311\n\nIncidental Airway Findings on PET/CT with 18F-PSMA\n\nJason Orciuolo, Akash Sharma, Ephraim E. Parent, Joseph M. Accurso, Manoj K. Jain, and Jason R. Young\n\nLiberty University College of Osteopathic Medicine, Lynchburg, Virginia\n\nJ Nucl Med 2023; 64:993\n\nSpecific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE Treatment\n\nJens Hemmingsson, Johanna Svensson, Andreas Hallqvist, Katja Smits, Viktor Johanson, and Peter Bernhardt\n\nDepartment of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden\n\nJ Nucl Med 2023; 64:1456-1462\n\nPerformance of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Evaluation of Erdheim–Chester Disease: A Comparison with 18F-FDG PET/CT\n\nJiangyu Ma, Qiao Yang, Li Huo, Jiawen Dai, Na Niu, and Xinxin Cao\n\nBeijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China\n\nJ Nucl Med 2023; 64:1385–1391\n\nLeft Ventricular Strain from Myocardial Perfusion PET Imaging: Method Development and Comparison to 2-Dimensional Echocardiography\n\nJingwen Huang, Adam J. Mitchell, Ernest V. Garcia, C. David Cooke, Russell Folks, Maria Pernetz, Abhinav Goyal, Marina Piccinelli, and Jonathon A. Nye\n\nDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia\n\nJ Nucl Med 2023; 64:932–939\n\nMolecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study\n\nJohanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs, and Frank M. Bengel\n\nDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany\n\nJ Nucl Med 2023; 64:1279–1286\n\nSomatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid Carcinoma\n\nJohanna S. Enke, Ralph A. Bundschuh, Georgine Wienand, Nic G. Reitsam, Malte Kircher, Christian H. Pfob, Constantin Lapa, and Alexander Dierks\n\nNuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany\n\nJ Nucl Med 2023; 64:2001\n\nImportance of Blood Glucose Management Before 18F-FDG PET/CT in 322 Patients with Bacteremia of Unknown Origin\n\nJordy P. Pijl, Andor W.J.M. Glaudemans, Olivier Gheysens, Riemer H.J.A. Slart, and Thomas C. Kwee\n\nMedical Imaging Center, Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands\n\nJ Nucl Med 2023; 64:1287–1294\n\n[177Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement\n\nJosefine Graef, Stephanie Bluemel, Winfried Brenner, Holger Amthauer, Peter Truckenmueller, David Kaul, Peter Vajkoczy, Julia S. Onken, and Christian Furth\n\nDepartment of Nuclear Medicine, Charité–Universitätsmedizin Berlin, Berlin, Germany\n\nJ Nucl Med 2023; 64:892–895\n\nToward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy\n\nJulia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M. Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe, and Guido Böning\n\nDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:767–774\n\nAn International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose\n\nJulia Brosch-Lenz, Suqi Ke, Hao Wang, Eric Frey, Yuni K. Dewaraja, John Sunderland, and Carlos Uribe\n\nDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada\n\nJ Nucl Med 2023; 64:1109–1116\n\nMarshalling the Potential of Auger Electron Radiopharmaceutical Therapy\n\nJulie Bolcaen, Mohamed A. Gizawy, Samantha Y.A. Terry, António Paulo, Bart Cornelissen, Aruna Korde, Jonathan Engle, Valery Radchenko, and Roger W. Howell\n\nSSC Laboratory, Radiation Biophysics, NRF iThemba LABS, Cape Town, South Africa\n\nJ Nucl Med 2023; 64:1344–1351\n\nAntihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer\n\nKilian Kluge, David Haberl, Holger Einspieler, Sazan Rasul, Sebastian Gutschmayer, Lukas Kenner, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Alexander Haug, and Marcus Hacker\n\nDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria\n\nJ Nucl Med 2023; 64:1730–1736\n\nSuperior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma\n\nKim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher, and Wolfgang P. Fendler\n\nDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:1049–1055\n\nPreclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT\n\nLena Koller, Markus Joksch, Sarah Schwarzenböck, Jens Kurth, Martin Heuschkel, Nadine Holzleitner, Roswitha Beck, Gunhild von Amsberg, Hans-Jürgen Wester, Bernd Joachim Krause, and Thomas Günther\n\nPharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany\n\nJ Nucl Med 2023; 64:1654–1659\n\n[68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis\n\nLena M. Unterrainer, Anthony E. Sisk, Johannes Czernin, Brian M. Shuch, Jeremie Calais. and Masatoshi Hotta\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California\n\nJ Nucl Med 2023; 64:1660–1661\n\nProstate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study\n\nLetizia Calderoni, Elisa Maietti, Andrea Farolfi, Riccardo Mei, Karly S. Louie, Michael Groaning, and Stefano Fanti\n\nNuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Di S. Orsola, Bologna, Italy\n\nJ Nucl Med 2023; 64:910–917\n\nClinical Evaluation of 68Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin αvβ3 in Various Cancer Types\n\nLiang Zhao, Xuejun Wen, Weizhi Xu, Yizhen Pang, Long Sun, Xiaoming Wu, Pengfei Xu, Jingjing Zhang, Zhide Guo, Qin Lin, Xiaoyuan Chen, and Haojun Chen\n\nDepartment of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Center, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China\n\nJ Nucl Med 2023; 64:1210–1217\n\nDosimetric Variability Across a Library of Computational Tumor Phantoms\n\nLukas M. Carter, Simone Krebs, Harry Marquis, Juan C. Ocampo Ramos, Edmond A. Olguin, Emilia O. Mason, Wesley E. Bolch, Pat B. Zanzonico, and Adam L. Kesner\n\nDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York\n\nJ Nucl Med 2023; 64:782–790\n\nPrognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy\n\nLukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D’Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Weber, and Matthias Eiber\n\nDepartment of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:896–901\n\nMIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals\n\nLukas M. Carter, Juan C. Ocampo Ramos, Edmond A. Olguin, Justin L. Brown, Daniel Lafontaine, Derek W. Jokisch, Wesley E. Bolch, and Adam L. Kesner\n\nDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York\n\nJ Nucl Med 2023; 64:1295–1303\n\n68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial\n\nLukas Kessler, Nader Hirmas, Kim M. Pabst, Rainer Hamacher, Justin Ferdinandus, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Michael Nader, Lale Umutlu, Waldemar Uhl, Anke Reinacher-Schick, Celine Lugnier, David Witte, Marco Niedergethmann, Ken Herrmann, Wolfgang P. Fendler, and Jens T. Siveke\n\nDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:1910–1917\n\nCorrelation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)\n\nMaeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns, and Roisin M. Connolly\n\nCancer Research @UCC, Cork, Ireland\n\nJ Nucl Med 2023; 64:1690–1696\n\nThree-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers\n\nMahnoosh Naeimi, Peter L. Choyke, Katharina Dendl, Yuriko Mori, Fabian Staudinger, Tadashi Watabe, Stefan A. Koerber, Manuel Röhrich, Jürgen Debus, Clemens Kratochwil, Uwe Haberkorn, and Frederik L. Giesel\n\nDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany\n\nJ Nucl Med 2023; 64:618–622\n\nDual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome\n\nManuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, Matthias Weissinger, Helmut Dittmann, Christian la Fougère, and Francesco Fiz\n\nDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany\n\nJ Nucl Med 2023; 64:1431–1438\n\nResponse Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing 18F-FDG PET/CT with Conventional CT\n\nMarianne Vogsen, Frederik Harbo, Nick M. Jakobsen, Henriette J. Nissen, Sara E. Dahlsgaard-Wallenius, Oke Gerke, Jeanette D. Jensen, Jon T. Asmussen, Anne Marie B. Jylling, Poul-Erik Braad, Werner Vach, Marianne Ewertz, and Malene G. Hildebrandt\n\nDepartment of Oncology, Odense University Hospital, Odense, Denmark\n\nJ Nucl Med 2023; 64:355–361\n\nThe Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer\n\nMarinus J. Hagens, Wietske I. Luining, Auke Jager, Maarten L. Donswijk, Zing Cheung, Maurits Wondergem, Daniela E. Oprea-Lager, André N. Vis, Pim J. van Leeuwen, and Henk G. van der Poel\n\nDepartment of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands\n\nJ Nucl Med 2023; 64:1238-1243\n\nTemporal Changes in Coronary 18F-Fluoride Plaque Uptake in Patients with Coronary Atherosclerosis\n\nMarwa Daghem, Philip D. Adamson, Kang-Ling Wang, Mhairi Doris, Rong Bing, Edwin J.R. van Beek, Laura Forsyth, Michelle C. Williams, Evangelos Tzolos, Damini Dey, Piotr J. Slomka, Marc R. Dweck, David E. Newby, and Alastair J. Moss\n\nBritish Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom\n\nJ Nucl Med 2023; 64:1478–1486\n\nAn Investigation of Lesion Detection Accuracy for Artificial Intelligence–Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms\n\nMathias Loft, Claes N. Ladefoged, Camilla B. Johnbeck, Esben A. Carlsen, Peter Oturai, Seppo W. Langer, Ulrich Knigge, Flemming L. Andersen, and Andreas Kjaer\n\nDepartment of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital–Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark\n\nJ Nucl Med 2023; 64:951–959\n\nComparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib\n\nMeiqi Wu, Yanyu Wang, Qiao Yang, Xuezhu Wang, Xu Yang, Haiqun Xing, Xinting Sang, Xiang Li, Haitao Zhao, and Li Huo\n\nDepartment of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China\n\nJ Nucl Med 2023; 64:1532–1539\n\nComparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-l-Glutamate as System Formula–Targeting Radiopharmaceuticals\n\nMilena Colovic, Hua Yang, Lily Southcott, Helen Merkens, Nadine Colpo, Francois Bénard, and Paul Schaffer\n\nLife Sciences Division, TRIUMF, Vancouver, British Columbia, Canada\n\nJ Nucl Med 2023; 64:1314–1321\n\nImaging of Activated T Cells\n\nMohammad O. Sako and Benjamin M. Larimer\n\nDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama\n\nJ Nucl Med 2023; 64:30–33\n\nFibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities\n\nNader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann, and Wolfgang P. Fendler\n\nDepartment of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium (DKTK)–University Hospital Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:711–716\n\nHybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases\n\nNathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins, and Michael C. Veronesi\n\nSchool of Medicine, Indiana University, Indianapolis, Indiana\n\nJ Nucl Med 2023; 64:1087–1092\n\n177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy\n\nNikeith John, Sarennya Pathmanandavel, Megan Crumbaker, William Counter, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Aron Poole, Adam Hickey, Shikha Agrawal, Gary Perkins, Annukka Kallinen, Enid Eslick, Martin R. Stockler, Anthony M. Joshua, Andrew Nguyen and Louise Emmett\n\nDepartment of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia\n\nJ Nucl Med 2023; 64:410–415\n\nFirst-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma\n\nNils Florian Trautwein, Gerald Reischl, Christian Seitz, Helmut Dittmann, Ferdinand Seith, Sophia Scheuermann, Tobias Feuchtinger, Frank Dombrowski, Rupert Handgretinger, Jörg Fuchs, Bernd Pichler, Christian la Fougère, and Johannes Schwenck\n\nDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen, Tübingen, Germany\n\nJ Nucl Med 2023; 64:337–338\n\nLong-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients\n\nNoémie S. Minczeles, Wouter W. de Herder, Richard A. Feelders, Frederik A. Verburg, Johannes Hofland, and Tessa Brabander\n\nSection of Endocrinology, Department of Internal Medicine, ENETS Centre of Excellence Rotterdam, Erasmus MC and Erasmus MC Cancer Centre, Rotterdam, The Netherlands\n\nJ Nucl Med 2023; 64:40–46\n\nPhase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)\n\nOdrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, Christel Fontaine, Denis Schallier, Sandrine Aspeslagh, Ilse Vaneycken, Geert Raes, Jo A. Van Ginderachter, Tony Lahoutte, Vicky Caveliers, and Marleen Keyaerts\n\nMIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium\n\nJ Nucl Med 2023; 64:1378–1384\n\nPreclinical Evaluation of 89Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis\n\nOlli Moisio, Jenni Virta, Emrah Yatkin, Heidi Liljenbäck, Senthil Palani, Riikka Viitanen, Maxwell W.G. Miner, Vesa Oikonen, Tuula Tolvanen, Danielle J. Vugts, Pekka Taimen, Xiang-Guo Li, Maija Hollmén, Sirpa Jalkanen, and Anne Roivainen\n\nTurku PET Centre, University of Turku, Turku, Finland\n\nJ Nucl Med 2023; 64:555–560\n\nIncidental Focal 68Ga-FAPI-46 Uptake in a Urachal Remnant: A Potential Pitfall Mimicking a Malignant Peritoneal Lesion\n\nPeter George Maliha, Mahbod Jafarvard, Johannes Czernin, Jeremie Calais, and Masatoshi Hotta\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California\n\nJ Nucl Med 2023; 64:992\n\nObstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET–Positive and [18F]FDG PET–Negative\n\nPeter George Maliha, Abie H. Mendelsohn, Johannes Czernin, Taylor Howard, Jeremie Calais, and Masatoshi Hotta\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California\n\nJ Nucl Med 2023; 64:1839–1840\n\nElevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy\n\nPhilipp E. Hartrampf, Patrick W. Mihatsch, Anna Katharina Seitz, Lilja B. Solnes, Steven P. Rowe, Martin G. Pomper, Hubert Kübler, Thorsten A. Bley, Andreas K. Buck, and Rudolf A. Werner\n\nDepartment of Nuclear Medicine, University Hospital of Würzburg, Würzburg, Germany\n\nJ Nucl Med 2023; 64:1272–1278\n\nLong Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab\n\nPhilipp Mohr, Joyce van Sluis, Laura Providência, Johannes H. van Snick, Marjolijn N. Lub-de Hooge, Antoon T. Willemsen, Andor W.J.M. Glaudemans, Ronald Boellaard, Adriaan A. Lammertsma, Adrienne H. Brouwers, and Charalampos Tsoumpas\n\nDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands\n\nJ Nucl Med 2023; 64:1815–1820\n\nPSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors\n\nQaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, Sideris Spyridon, Romain Diamand, Albert Santapau, Alexandre Peltier, Thierry Roumeguère, Patrick Flamen, and Carlos Artigas\n\nDepartment of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium\n\nJ Nucl Med 2023; 64:1869–1875\n\nUnspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer\n\nRobert Seifert, Tugce Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann, and Wolfgang P. Fendler\n\nDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:738–743\n\nIs 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis\n\nRobert Seifert, Tugce Telli, Boris Hadaschik, Wolfgang P. Fendler, Phillip H. Kuo, and Ken Herrmann\n\nDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:731–737\n\nAutomated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET\n\nRobin Gutsche, Carsten Lowis, Karl Ziemons, Martin Kocher, Garry Ceccon, Cláudia Régio Brambilla, Nadim J. Shah, Karl-Josef Langen, Norbert Galldiks, Fabian Isensee, and Philipp Lohmann\n\nInstitute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany\n\nJ Nucl Med 2023; 64:1594–1602\n\nDetection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW\n\nRuben Y. Gabriëls, Lisanne E. van Heijst, Wouter T.R. Hooghiemstra, Anne M. van der Waaij, Gursah Kats-Ugurlu, Arend Karrenbeld, Dominic J. Robinson, Anna Tenditnaya, Vasilis Ntziachristos, Dimitris Gorpas, and Wouter B. Nagengast\n\nDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands\n\nJ Nucl Med 2023; 64:803–808\n\nAn Experimental Generator for Production of High-Purity 212Pb for Use in Radiopharmaceuticals\n\nRuth Gong Li, Vilde Yuli Stenberg and Roy Hartvig Larsen\n\nInstitute of Clinical Medicine, University of Oslo, Oslo, Norway\n\nJ Nucl Med 2023, 64:173–176\n\nOptimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets\n\nShefali Saini, Jennifer L. Bartels, Jean-Pierre K. Appiah, Jason H. Rider, Nicholas Baumhover, Michael K. Schultz, and Suzanne E. Lapi\n\nDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama\n\nJ Nucl Med 2023; 64:1791–1797\n\nMolecular Imaging, Radiochemistry, and Environmental Pollutants\n\nSamantha Delaney, Joni Sebastiano, Brian M. Zeglis, and Outi M. Keinänen\n\nDepartment of Chemistry, Hunter College, City University of New York, New York, New York\n\nJ Nucl Med 2023; 64:1179–1184\n\nMetformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors\n\nSandeep Surendra Panikar, Nai Keltee, Na-Keysha Berry, Shayla Shmuel, Zachary T. Fisher, Emma Brown, Abbey Zidel, Alex Mabry, and Patrícia M.R. Pereira\n\nDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri\n\nJ Nucl Med 2023; 64:1195–1202\n\nSurvival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study\n\nSanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo, and Chandrasekhar Bal\n\nDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India\n\nJ Nucl Med 2023; 64:211–218\n\nThe Prognostic Value of Posttreatment 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)\n\nSarennya Pathmanandavel, Megan Crumbaker, Andrew Nguyen, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Peter Eu, Andrew J. Martin, Martin R. Stockler, Anthony M. Joshua, and Louise Emmett\n\nDepartment of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia\n\nJ Nucl Med 2023; 64:69–74\n\nEvaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)\n\nSarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen, and Louise Emmett\n\nDepartment of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, Sydney, New South Wales, Australia\n\nJ Nucl Med 2023; 64:221–226\n\nEfficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis\n\nSebastian K. Chung, Daniela Burnes Vargas, Christopher S. Chandler, Sumudu Katugampola, Darren R. Veach, Michael R. McDevitt, Shin H. Seo, Brett A. Vaughn, Sara S. Rinne, Blesida Punzalan, Mitesh Patel, Hong Xu, Hong-Fen Guo, Pat B. Zanzonico, Sébastien Monette, Guangbin Yang, Ouathek Ouerfelli, Garrett M. Nash, Andrea Cercek, Edward K. Fung, Roger W. Howell, Steven M. Larson, Sarah M. Cheal, and Nai-Kong V. Cheung\n\nDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York\n\nJ Nucl Med 2023; 64:1439–1445\n\nThe Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to 177Lu-Prostate-Specific Membrane Antigen Therapy\n\nShejil Kumar, Megan Crumbaker, Christopher Harvey, Sarennya Pathmanandavel, Nikieth John, Mina M. Swiha, Michelle M. McDonald, Roderick Clifton-Bligh, Adrian Lee, Patricia Bastick, William Counter, Andrew Nguyen, and Louise Emmett\n\nDepartment of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia\n\nJ Nucl Med 2023; 64:1412–1416\n\nRadiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression\n\nSimon Isser, Andreas Maurer, Gerald Reischl, Martin Schaller, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Meinrad Gawaz, Bernd J. Pichler, and Nicolas Beziere\n\nWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University of Tübingen, Tübingen, Germany\n\nJ Nucl Med 2023; 64:940–945\n\nFibroblast Activation Protein–Targeted Radioligand Therapy for Treatment of Solid Tumors\n\nSpencer D. Lindeman, Ramesh Mukkamala, Autumn Horner, Pooja Tudi, Owen C. Booth, Roxanne Huff, Joshua Hinsey, Anders Hovstadius, Peter Martone, Fenghua Zhang, Madduri Srinivasarao, Abigail Cox, and Philip S. Low\n\nDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana\n\nJ Nucl Med 2023; 64:759–766\n\nImaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET\n\nSpenser R. Simpson, Alexandria E. Kesterson, Justin H. Wilde, Zoraiz Qureshi, Bijoy Kundu, Mark P. Simons, and Kiel D. Neumann\n\nDepartment of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, Tennessee\n\nJ Nucl Med 2023; 64:809–815\n\nSite-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET\n\nStanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke, and Freddy E. Escorcia\n\nMolecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland\n\nJ Nucl Med 2023; 64:1017–1023\n\n[177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis\n\nSwayamjeet Satapathy, Ranjit K. Sahoo, and Chandrasekhar Bal\n\nDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India\n\nJ Nucl Med 2023; 64:1266–1271\n\n[177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial\n\nSwayamjeet Satapathy, Bhagwant Rai Mittal, Ashwani Sood, Chandan Krushna Das, Ravimohan Suryanarayan Mavuduru, Shikha Goyal, Jaya Shukla, and Shrawan Kumar Singh\n\nDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India\n\nJ Nucl Med 2023; 64:1726–1729\n\nSomatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans\n\nTaymeyah Al-Toubah, Jaime Montilla-Soler, Ghassan El-Haddad, Mintallah Haider, and Jonathan Strosberg\n\nDepartment of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida\n\nJ Nucl Med 2023; 64:1895–1898\n\nTargeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment\n\nThomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Cleo Goyvaerts, Kim De Veirman, Alfred Morgenstern, Frank Bruchertseifer, Marleen Keyaerts, Nick Devoogdt, Matthias D’Huyvetter, and Karine Breckpot\n\nDepartment of Biomedical Sciences, Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium\n\nJ Nucl Med 2023; 64:751–758\n\n18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models\n\nThuc M. Le, Hailey R. Lee, Evan R. Abt, Khalid Rashid, Amanda L. Creech, Keke Liang, Jing Cui, Arthur Cho, Liu Wei, Amanda Labora, Charlotte Chan, Eric Sanchez, Kriti Kriti, Daniel Karin, Luyi Li, Nanping Wu, Christine Mona, Giuseppe Carlucci, Willy Hugo, Ting-Ting Wu, Timothy R. Donahue, Johannes Czernin, and Caius G. Radu\n\nMolecular and Medical Pharmacology, UCLA, Los Angeles, California\n\nJ Nucl Med 2023; 64:117–123\n\nPredicting Outcomes of Indeterminate Bone Lesions on 18F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer\n\nTim E. Phelps, Stephanie A. Harmon, Esther Mena, Liza Lindenberg, Joanna H. Shih, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke, and Baris Turkbey\n\nMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland\n\nJ Nucl Med 2023; 64:395-401\n\nUtility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis\n\nTimo Schlürmann, Birgit Waschulzik, Stephanie Combs, Jens Gempt, Benedikt Wiestler, Wolfgang Weber, and Igor Yakushev\n\nDepartment of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany\n\nJ Nucl Med 2023; 64:816–821\n\nNovel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls\n\nTristan T. Demmert, Ines Maric, Kelsey L. Pomykala, Katharina Lueckerath, Jens Siveke, Benedikt M. Schaarschmidt, Rainer Hamacher, Ken Herrmann, and Wolfgang P. Fendler\n\nDepartment of Nuclear Medicine, West German Cancer Center, University of Duisburg–Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:368–371\n\nOncologic Staging with 68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET/CT\n\nTristan T. Demmert, Kelsey L. Pomykala, Helena Lanzafame, Kim M. Pabst, Katharina Lueckerath, Jens Siveke, Lale Umutlu, Hubertus Hautzel, Rainer Hamacher, Ken Herrmann, and Wolfgang P. Fendler\n\nDepartment of Nuclear Medicine, West German Cancer Center, University of Duisburg-Essen, Essen, Germany\n\nJ Nucl Med 2023; 64:1906–1909\n\nNeurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine\n\nTudor M. Ionescu, Mario Amend, Tadashi Watabe, Jun Hatazawa, Andreas Maurer, Gerald Reischl, Bernd J. Pichler, Hans F. Wehrl, and Kristina Herfert\n\nWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Tuebingen, Germany\n\nJ Nucl Med 2023; 64:466–471\n\nConsecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer\n\nValentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmüller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Shahrokh Shariat, Gerda Egger, and Markus Zeitlinger\n\nLudwig Boltzmann Institute Applied Diagnostics, Vienna, Austria\n\nJ Nucl Med 2023; 64:863–868\n\nPretargeting with Cucurbituril–Adamantane Host–Guest Pair in Xenograft Models\n\nVilma I.J. Jallinoja, Courtney H. Abbriano, Kavita Bhatt, Amritjyot Kaur, David J. Schlyer, Paul J. Yazaki, Brandon D. Carney, and Jacob L. Houghton\n\nDepartment of Radiology, Stony Brook University, Stony Brook, New York\n\nJ Nucl Med 2023; 64:1203–1209\n\nPSMA-Negative Lesion Progression Under 177Lu-PSMA Radioligand Therapy\n\nVishnu Murthy, Martin Allen-Auerbach, Richard Lam, Dawn Owen, Johannes Czernin, and Jeremie Calais\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California\n\nJ Nucl Med 2023; 64:1502-1503\n\nPrognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis\n\nVishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin, and Jeremie Calais\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California\n\nJ Nucl Med 2023; 64:1737–1743\n\nAlbumin-Binding and Conventional PSMA Ligands in Combination with 161Tb: Biodistribution, Dosimetry, and Preclinical Therapy\n\nViviane J. Tschan, Sarah D. Busslinger, Peter Bernhardt, Pascal V. Grundler, Jan Rijn Zeevaart, Ulli Köster, Nicholas P. van der Meulen, Roger Schibli, and Cristina Müller\n\nCenter for Radiopharmaceutical Sciences ETH–PSI, Paul Scherrer Institute, Villigen-PSI, Switzerland\n\nJ Nucl Med 2023; 64:1625–1631\n\nResponse Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy\n\nXinying Hu, Tao Zhou, Jiazhong Ren, Jinghao Duan, Hongbo Wu, Xiaoli Liu, Zhengshuai Mu, Ning Liu, Yuchun Wei, and Shuanghu Yuan\n\nDepartment of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China\n\nJ Nucl Med 2023; 64:625–631\n\nFibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT\n\nXuetao Chen, Shuailiang Wang, Yumei Lai, Guochang Wang, Maomao Wei, Xiao Jin, Jin Ding, Yan Zhang, Yunfei Shi, Feng Wang, Hua Zhu, Zhi Yang, and Xuejuan Wang\n\nKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Medical Products Association, Key Laboratory for Research and Evaluation of Radiopharmaceuticals, National Medical Products Association, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China\n\nJ Nucl Med 2023; 64:1399–1405\n\nHigh-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections\n\nYiran Wang, Benjamin A. Spencer, Jeffrey Schmall, Elizabeth Li, Ramsey D. Badawi, Terry Jones, Simon R. Cherry, and Guobao Wang\n\nDepartment of Radiology, University of California Davis Medical Center, Sacramento, California\n\nJ Nucl Med 2023; 64:1154–1161\n\nTotal-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery\n\nYiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang\n\nDepartment of Radiology, Davis Medical Center, University of California, Sacramento, California\n\nJ Nucl Med 2023; 64:1821–1830\n\nPrognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis\n\nVishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin, and Jeremie Calais\n\nAhmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California\n\nJ Nucl Med 2023; 64:1737–1743\n\nPET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study\n\nYizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Long Sun, and Haojun Chen\n\nDepartment of Nuclear Medicine and Minnan PET Center, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China\n\nJ Nucl Med 2023; 64:386–394\n\nDevelopment of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy\n\nYizhen Pang, Liang Zhao, Jianyang Fang, Jianhao Chen, Lingxin Meng, Long Sun, Hua Wu, Zhide Guo, Qin Lin, and Haojun Chen\n\nDepartment of Nuclear Medicine and Minnan PET Center, Xiamen Key Laboratory of Radiopharmaceuticals, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China\n\nJ Nucl Med 2023; 64:1449–1455\n\nEffective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment\n\nYutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan, and Michael R. Zalutsky\n\nDepartment of Radiology, Duke University Medical Center, Durham, North Carolina\n\nJ Nucl Med 2023; 64:124–130\n\nERF SNMMI JNM Best Paper Awards -\n\nThe Journal of Nuclear MedicineEditors’ Choice AwardFOR THE BEST CLINICAL ARTICLE IN 2023\n\nis presented to\n\nJohanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs, and Frank M. Bengel\n\nDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany\n\nfor\n\nMolecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study\n\nJ Nucl Med. 2023; 64:1279–1286\n\nThe Journal of Nuclear MedicineEditors’ Choice AwardFOR THE BEST BASIC SCIENCE ARTICLE IN 2023\n\nis presented to\n\nSpencer D. Lindeman, Ramesh Mukkamala, Autumn Horner, Pooja Tudi, Owen C. Booth, Roxanne Huff, Joshua Hinsey, Anders Hovstadius, Peter Martone, Fenghua Zhang, Madduri Srinivasarao, Abigail Cox, and Philip S. Low\n\nDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, Indiana\n\nfor\n\nFibroblast Activation Protein–Targeted Radioligand Therapy for Treatment of Solid Tumors\n\nJ Nucl Med. 2023; 64:759–766\n\nThe Journal of Nuclear MedicineEditors’ Choice AwardFOR THE OVERALL BEST ARTICLE IN 2023\n\nis presented to\n\nJohanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs, and Frank M. Bengel\n\nDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany\n\nfor\n\nMolecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study\n\nJ Nucl Med. 2023; 64:1279–1286\n\nERF-SNMMI-TS JNMT Outstanding Article Awards -\n\nJournal of Nuclear Medicine TechnologyOutstanding Article AwardFOR 1ST PLACE ARTICLE IN 2023\n\nis presented to\n\nSkyla Bamforth, Daphne J. James, Christopher Skilton, and Anthony Smith\n\nSchool of Health Sciences, University of Newcastle, Callaghan, New South Wales, Australia\n\nfor\n\nInvestigating a Technologist-Driven Injection Technique in Lymphoscintigraphy at a Single Rural Center: A Retrospective Audit\n\nNucl. Med. Technol. 2023, 51:220–226\n\nJournal of Nuclear Medicine TechnologyOutstanding Article AwardFOR 2ND PLACE ARTICLE IN 2023\n\nis presented to\n\nStephen Edmonds, Jennifer Davidson, Rosanne Joseph, and Madhusudan Vyas\n\nMercy Radiology, Auckland, New Zealand\n\nfor\n\nImaging Pathway of a Pediatric Patient with Succinate Dehydrogenase B-Deficient Paraganglioma\n\nNucl. Med. Technol. 2023, 51:318–322\n\nJournal of Nuclear Medicine TechnologyOutstanding Article AwardFOR 3RD PLACE ARTICLE IN 2023\n\nis presented to\n\nJaime Warren\n\nMedAxiom, Neptune Beach, Florida\n\nfor\n\nAlternative Isotope Options for Amyloidosis Imaging: A Technologist’s Perspective\n\nNucl. Med. Technol. 2023, 51:117–119\n\nJournal of Nuclear Medicine TechnologyOutstanding Article AwardFOR BEST CONTINUING EDUCATION ARTICLE IN 2023\n\nis presented to\n\nMonica Embry-Dierson, Mary Beth Farrell, Eric Schockling, Jaime Warren, and Scott Jerome\n\nNoninvasive Cardiology, Norton Audubon Hospital, Louisville, Kentucky\n\nfor\n\nCardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition\n\nNucl. Med. Technol. 2023, 51:83–89\n\nJournal of Nuclear Medicine TechnologyOutstanding Article AwardFOR BEST EDUCATORS’ FORUM ARTICLE IN 2023\n\nis presented to\n\nGeoffrey Currie and Kym Barry\n\nCharles Sturt University, Wagga Wagga, New South Wales, Australia\n\nfor\n\nChatGPT in Nuclear Medicine Education\n\nNucl. Med. Technol. 2023, 51:247–254\n\nSusan C. Weiss Clinical Advancement Scholarship - n/a 2024\n\nERF-SNMMI-TS Bachelor's or Master's Degree Completion Scholarship - Brianna Reidel\n\nERF-SNMMI-TS Advanced Degree Scholarship - Keexia Osborne, CNMT"
    }
}